Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$168M |
| 2 |
Exxon Mobil
XOM
|
$120M |
| 3 |
GE HealthCare
GEHC
|
$103M |
| 4 |
Visa
V
|
$96.1M |
| 5 |
Meta Platforms (Facebook)
META
|
$92.1M |
Top Sells
| 1 |
Walmart
WMT
|
$331M |
| 2 |
JPMorgan Chase
JPM
|
$199M |
| 3 |
GE Aerospace
GE
|
$102M |
| 4 |
Thermo Fisher Scientific
TMO
|
$98.9M |
| 5 |
ConocoPhillips
COP
|
$80.4M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.08% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNCB
3126
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $295K | ﹤0.01% |
47,621
+20,875
| +78% | +$130K |
|
|
HALL
3127
DELISTED
Hallmark Financial Services, Inc.
HALL
| $292K | ﹤0.01% |
+44,951
| New | +$292K |
|
3128
Monte Rosa Therapeutics
GLUE
$305M
| $290K | ﹤0.01% |
+37,268
| New | +$290K |
|
3129
Cytosorbents Corp
CTSO
$60.6M
| $290K | ﹤0.01% |
86,016
-7,263
| -8% | -$24.5K |
|
3130
SWK Holdings
SWKH
$178M
| $290K | ﹤0.01% |
20,473
+166
| +0.8% | +$2.35K |
|
|
AYX
3131
DELISTED
Alteryx, Inc.
AYX
| $289K | ﹤0.01% |
4,918
| – | – |
|
|
INZY
3132
DELISTED
Inozyme Pharma
INZY
| $287K | ﹤0.01% |
50,577
+28,370
| +128% | +$161K |
|
3133
Pathfinder Bancorp
PBHC
$92.5M
| $285K | ﹤0.01% |
16,517
| – | – |
|
|
FORTY
3134
Formula Systems
FORTY
$2.1B
| $283K | ﹤0.01% |
4,303
| – | – |
|
3135
Karat Packaging
KRT
$512M
| $282K | ﹤0.01% |
+21,154
| New | +$282K |
|
3136
CKX Lands
CKX
$24.2M
| $282K | ﹤0.01% |
29,876
-1,142
| -4% | -$10.8K |
|
3137
Stereotaxis
STXS
$264M
| $279K | ﹤0.01% |
136,959
-10,559
| -7% | -$21.5K |
|
3138
Ring Energy
REI
$207M
| $279K | ﹤0.01% |
146,899
| – | – |
|
|
SPPI
3139
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $279K | ﹤0.01% |
371,792
-67,931
| -15% | -$50.9K |
|
3140
Viridian Therapeutics
VRDN
$1.53B
| $278K | ﹤0.01% |
10,926
-472
| -4% | -$12K |
|
|
SUNE
3141
SUNation Energy, Inc. Common Stock
SUNE
$4.97M
| $278K | ﹤0.01% |
1
| – | – |
|
3142
Paymentus
PAY
$4.62B
| $276K | ﹤0.01% |
+31,186
| New | +$276K |
|
3143
Great Elm Group
GEG
$79.7M
| $274K | ﹤0.01% |
120,736
| – | – |
|
3144
Smart Sand
SND
$75.9M
| $274K | ﹤0.01% |
155,694
-17,769
| -10% | -$31.3K |
|
3145
Synlogic
SYBX
$17.1M
| $274K | ﹤0.01% |
28,888
-2,524
| -8% | -$23.9K |
|
3146
Lake Shore Bancorp
LSBK
$103M
| $272K | ﹤0.01% |
26,934
+1,707
| +7% | +$17.2K |
|
3147
Acumen Pharmaceuticals
ABOS
$87.2M
| $271K | ﹤0.01% |
+66,779
| New | +$271K |
|
3148
DarioHealth
DRIO
$23M
| $267K | ﹤0.01% |
3,244
+62
| +2% | +$5.11K |
|
3149
Solid Biosciences
SLDB
$428M
| $267K | ﹤0.01% |
56,335
+597
| +1% | +$2.83K |
|
|
HCP
3150
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $266K | ﹤0.01% |
9,088
+1,172
| +15% | +$34.3K |
|